Paradoxically, genetically modified mice with IL-18 deficiency have been reported to develop hyperphagia, obesity and insulin resistance, which might be reversed by recombinant IL-18 administration [84]. The gene discussed is IL18; the disease is obesity due to melanocortin 4 receptor deficiency.